GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

Gene-based blood test for melanoma may detect early signs of cancer return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.

April 18, 2025

Vol.51 No.15

Drugs & Targets

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Exact Sciences Corp. announced the launch of Cologuard Plus, the most accurate noninvasive colorectal cancer screening test reported in studies to date. FDA-approved for average-risk patients 45+ and covered by Medicare, the Cologuard Plus test detects 95% of colorectal cancers at 94% specificity in the U.S. screening population.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine explore the effect of the pandemic on colorectal cancer screening tests and diagnostic colonoscopies in central Indiana.

March 28, 2025

Vol.51 No.12

In Brief

UVA Health expands breast cancer screening with mobile 3D mammography coach

To expand access to breast cancer screening for patients across Virginia, UVA Health is rolling out a new mobile mammography coach.

February 28, 2025

Vol.51 No.08

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

Over the last 45 years, prevention and screening interventions have made a greater contribution to averting cancer deaths than have improvements in treatment, according to a modeling study led by researchers at NCI.

January 31, 2025

Vol.51 No.04

By Yiqing Wang and Jacquelyn Cobb

ACS report: Cancer mortality continues to drop despite rising incidence in women

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men.

January 17, 2025

Vol.51 No.02

By Yiqing Wang

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

YOU MAY BE INTERESTED IN

Gene-based blood test for melanoma may detect early signs of cancer return

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

UVA Health expands breast cancer screening with mobile 3D mammography coach

NCI study: Prevention and screening saved more lives than treatment in five common cancer types over the past half-century

ACS report: Cancer mortality continues to drop despite rising incidence in women

Renew today!

Subscriber content

Never miss an issue!

Login